Cancer cure threat

INDEPENDENT clinical trials of new cancer therapies are threatened by the market-style changes to the NHS, says the UK Co-ordinating Committee on Cancer Research - an independent group representing researchers. It says there is now a greater reliance on trials paid for by drug companies.